Compal is set to participate in the 2024 Healthy Ageing Tech Show, taking place from August 2 to 4 at the Taipei World Trade Center Hall 1. This year, Compal will showcase several smart health innovations, covering remote rehabilitation, elderly care, stress assessment, and hearing solutions. Participating subsidiaries and units include Shennona, Compal Health, HippoScreen Neurotech, Andhear, and General Life Biotechnology. Compal Chairman Jui-Tsung Chen stated that over the past seven years, Compal has made significant progress in various medical fields. As Taiwan approaches a super-aged society by 2025, the group will continue to expand its smart healthcare investments to help alleviate the societal burden of health care.
Shennona will showcase the "AI-Assisted Activity Assessment," a dynamic sensor for remote rehabilitation. This device can transmit doctors' rehabilitation recommendations to patients at home via the cloud, reducing the need for frequent clinic visits.
Compal Health will present Taiwan's largest care platform, offering enterprise cloud ERP and integrated health and care management and education network. Since its launch in 2018, it has been adopted by over 1,500 institutions, providing 250 million care services to 600,000 elderly individuals, significantly enhancing care quality and professional caregivers' skills.
HippoScreen Neurotech will feature its "AI Brainwave Stress & Dementia Risk Assessment" product. By analyzing 90-second brainwave signals in real-time, this tool provides quantifiable stress assessment indicators, making it a powerful tool for mental health screening and clinical diagnostics.
Andhear will showcase products for the professional hearing market, including the Andvoice Hearing Test Kit, Andpods Professional Hearing Aids, and TV streaming devices. These solutions offer comprehensive hearing care, from precise customer targeting and a diverse product line to excellent after-sales service, catering to hearing centers, chains, and medical institutions, thereby boosting consumer satisfaction and sales goals.
General Life Biotechnology will display the "4in1 Family Health Choice" flagship multifunctional blood glucose meter. Designed for families and clinical settings, it is easy to operate and can sync data to a mobile app, allowing users to monitor their health anytime.
This comprehensive display of smart health solutions reflects Compal's ongoing commitment to leveraging technology to improve healthcare outcomes and meet the growing needs of an aging population.
Resource (mandarin): 仁寶參展高齡健康產業博覽會 秀智慧健康布局成果
